Abstract

Introduction: The reported incidence of ventilator-associated pneumonia (VAP) in Wales is low compared with surveillance data from other European regions. It is unclear whether this reflects success of the Welsh healthcare-associated infection prevention measures or limitations in the application of European VAP surveillance methods. Our primary aim was to investigate episodes of ventilator-associated respiratory tract infection (VARTI), to identify episodes that met established criteria for VAP, and to explore reasons why others did not, according to the Hospitals in Europe Link for Infection Control through Surveillance (HELICS) definitions.Materials and Methods: During two 14-day study periods 2012–2014, investigators reviewed all invasively ventilated patients in all 14 Welsh Intensive Care Units (ICUs). Episodes were identified in which the clinical team had commenced antibiotic therapy because of suspected VARTI. Probability of pneumonia was estimated using a modified Clinical Pulmonary Infection Score (mCPIS). Episodes meeting HELICS definitions of VAP were identified, and reasons for other episodes not meeting definitions examined. In the second period, each patient was also assessed with regards to the development of a ventilator-associated event (VAE), according to recent US definitions.Results: The study included 306 invasively ventilated patients; 282 were admitted to ICU for 48 h or more. 32 (11.3%) patients were commenced on antibiotics for suspected VARTI. Ten of these episodes met HELICS definitions of VAP, an incidence of 4.2 per 1000 intubation days. In 48% VARTI episodes, concurrent chest radiography was not performed, precluding the diagnosis of VAP. Mechanical ventilation (16.0 vs. 8.0 days; p = 0.01) and ICU stay (25.0 vs. 11.0 days; p = 0.01) were significantly longer in patients treated for VARTI compared to those not treated. There was no overlap between episodes of VARTI and of VAE.Discussion: HELICS VAP surveillance definitions identified less than one-third of cases in which antibiotics were commenced for suspected ventilator-associated RTI. Lack of chest radiography precluded nearly 50% cases from meeting the surveillance definition of VAP, and as a consequence we are almost certainly underestimating the incidence of VAP in Wales.

Highlights

  • The reported incidence of ventilator-associated pneumonia (VAP) in Wales is low compared with surveillance data from other European regions

  • Mortality was high in the group of patients with Ventilator-Associated Conditions” (VACs) but we found no overlap with our ventilator-associated respiratory tract infection (VARTI) cohort

  • Our data suggest that established measurements of VAP rates in Wales have under-estimated the true incidence of VAP

Read more

Summary

Introduction

The reported incidence of ventilator-associated pneumonia (VAP) in Wales is low compared with surveillance data from other European regions. Using European HELICS surveillance definitions (Table 1; HELICS, 2004) clinical staff in each ICU have reported VAP episodes equivalent to an incidence density of 1.2–2.2 per 1000 intubation days for 2009–2013 (WHAIP, 2014) These rates are low when compared to data from other areas of the UK (Scotland, 6.5 per 1000 intubation days; HPS/SICSAG, 2013) and Europe (12.2 per 1000 intubation days; ECDC, 2008). This may reflect the success of national healthcare improvement initiatives in Wales (e.g., the 1000 Lives Campaign), but could feasibly underestimate the true incidence of ventilator-associated pneumonia (VAP) given how subjective the clinical and radiological features of VAP can be (Klompas, 2012). Such “Ventilator-Associated Conditions” (VACs) may potentially be sub-classified according to other unambiguous features (temperature, white cell count, and initiation of antibiotic therapy) as an Infection-related Ventilator-Associated Complication (I-VAC) for mandatory surveillance purposes

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call